NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
NATCO records INR 2811.7 Crore consolidated revenue and INR 715.3 Crore of Profit after tax for the year ended March 31st, 202329-05-2023
29-05-2023
NATCO PHARMA LTD. - 524816 - Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31St March, 2023
Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 202329-05-2023
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Extinguishment of 2588716 Equity shares of the Company bought under Buyback23-05-2023
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Q4 FY23 Financial Results Earnings Call23-05-2023
NATCO PHARMA LTD. - 524816 - Board Meeting Intimation for Approval Of Audited Financial Results
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve the Audited Financial Results for the quarter and year ended 31st March, 202319-05-2023
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificate17-05-2023
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Post Buyback Public Announcement
This is further to our intimation dated May 12, 2023, and pursuant to Regulation 24 (vi) of the Buyback Regulations, please note that today i.e. on May 16, 2023, the Company has published the Post Buyback Public Announcement dated May 15, 2023 for the buyback of its equity shares of face value ? 2/- each, in Business Standard (English national daily newspaper - All editions), Business Standard (Hindi national daily newspaper- All editions) and Nava Telangana (Telugu daily newspaper, Hyderabad Edition, Telugu being the regional language of Hyderabad wherein the registered office of the Company is located)16-05-2023
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Closure of Buy Back
Natco Pharma Limited has informed the Exchange regarding Closure of Buy Back with effect from May 12, 202312-05-2023
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Daily report pursuant to Regulation 18(i) of the Buyback Regulations regarding the equity shares bought-back on May 11, 2023. Total no. of equity shares bought back are 60607111-05-2023